Neuroquímida y Neurodegeneración
Instituto de Investigación Sanitaria Biogipuzkoa
San Sebastián, EspañaPublicacions en col·laboració amb investigadors/es de Instituto de Investigación Sanitaria Biogipuzkoa (9)
2021
-
Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome
Nature Communications, Vol. 12, Núm. 1
-
Human-lineage-specific genomic elements are associated with neurodegenerative disease and APOE transcript usage
Nature Communications, Vol. 12, Núm. 1
2020
-
Regulatory sites for splicing in human basal ganglia are enriched for disease-relevant information
Nature Communications, Vol. 11, Núm. 1
2019
-
Mitochondria function associated genes contribute to Parkinson’s Disease risk and later age at onset
npj Parkinson's Disease, Vol. 5, Núm. 1
-
Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson’s disease heritability
npj Parkinson's Disease, Vol. 5, Núm. 1
-
SNCA and mTOR Pathway Single Nucleotide Polymorphisms Interact to Modulate the Age at Onset of Parkinson's Disease
Movement Disorders, Vol. 34, Núm. 9, pp. 1333-1344
-
The Genetic Architecture of Parkinson Disease in Spain: Characterizing Population-Specific Risk, Differential Haplotype Structures, and Providing Etiologic Insight
Movement Disorders, Vol. 34, Núm. 12, pp. 1851-1863
2016
-
Dysexecutive syndrome in amnesic mild cognitive impairment: A multicenter study
BMC Neurology, Vol. 16, Núm. 1
2015
-
Autonomic involvement in Parkinsonian carriers of PARK2 gene mutations
Parkinsonism and Related Disorders, Vol. 21, Núm. 7, pp. 717-722